Vimarsana
Biggest News Aggregation in the World

Greg Licholai News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Greg Licholai. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Greg Licholai Today - Breaking & Trending Today

EB Research Partnership and Jill and Eddie Vedder Raised Over $5M to Benefit Life-Saving Rare Disease Research - Vimarsana News

EB Research Partnership and Jill and Eddie Vedder Raised Over $5M to Benefit Life-Saving Rare Disease Research

Eddie Vedder played two intimate concerts in his hometown of Seattle at Benaroya Hall on October 23rd and 24th to bring support to a cause that is near to his heart – EB Research Partnership (EBRP).

EB Research Partnership to host inaugural Venture Into Cures Summit & Dinner in Seattle alongside Eddie Vedder solo shows - Vimarsana News

EB Research Partnership to host inaugural Venture Into Cures Summit & Dinner in Seattle alongside Eddie Vedder solo shows

NEW YORK--(BUSINESS WIRE)--Sep 12, 2023--

The Long-Term Impact Of COVID-19 On Clinical Trials Part 1 - Vimarsana News

The Long-Term Impact Of COVID-19 On Clinical Trials Part 1

Pandemics provide a massive pressure-test of healthcare systems, allowing us to isolate what works well and what merits improvement. The COVID-19...

FDA approves first gene-edited cows for beef -- Health & Wellness -- Sott.net - Vimarsana News

FDA approves first gene-edited cows for beef -- Health & Wellness -- Sott.net

In as little as two years, Americans could be biting into their first gene-edited burgers, courtesy of the U.S. Food and Drug Administration's (FDA) regulatory clearance of gene-edited cattle. The animals, created by bioengineering company...

Source: sott.net
PRA Health Sciences expands its response to COVID-19 with pharmacovigilance solutions for authorized vaccines and therapeutics - News Makers - Vimarsana News

PRA Health Sciences expands its response to COVID-19 with pharmacovigilance solutions for authorized vaccines and therapeutics - News Makers

PRA Health Sciences expands its response to COVID-19 with pharmacovigilance solutions for authorized vaccines and therapeutics PRA offers post-authorization safety solutions to keep up with the speed of COVID-19 vaccine and therapeutic pharmacovigilance requirements RALEIGH, N.C., April 21, 2021 (GLOBE NEWSWIRE) — PRA Health Sciences (NASDAQ: PRAH) announced today the expansion of its pharmacovigilance solution to offer full post-marketing services for authorized COVID-19 vaccines and therapeutics, including post-authorization safety studies (PASS) delivered by Real World Solutions. With mo...